Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc.

Pharmaceutical Manufacturing

Redwood City, California 4,610 followers

Inspired by patients and families around the world, we are advancing much needed therapies for rare genetic disorders.

About us

At Soleno, we are researching and developing medicines to treat rare genetic disorders, beginning with Prader-Willi syndrome (PWS), a life-threatening neurobehavioral, metabolic and endocrine disorder characterized by hyperphagia (insatiable hunger), neurocognitive and behavioral difficulties. Our lead candidate, DCCR, is a Phase 3, once-daily oral tablet under investigation as a potential treatment for PWS. Our priority is to bring the first approved treatment to patients to manage the most burdensome aspects of this devastating disorder.

Website
https://soleno.life/
Industry
Pharmaceutical Manufacturing
Company size
11-50 employees
Headquarters
Redwood City, California
Type
Public Company
Specialties
Biopharmaceuticals, Therapeutics for the treatment of rare diseases, and Pharmaceuticals

Locations

  • Primary

    203 Redwood Shores Parkway

    Suite 500

    Redwood City, California 94065, US

    Get directions

Employees at Soleno Therapeutics, Inc.

Updates

Similar pages

Browse jobs

Funding

Soleno Therapeutics, Inc. 4 total rounds

Last Round

Post IPO equity

US$ 158.7M

See more info on crunchbase